Biogen (BIIB) News Today $128.00 -2.67 (-2.04%) Closing price 08/11/2025 04:00 PM EasternExtended Trading$128.15 +0.15 (+0.11%) As of 05:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIIB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Entropy Technologies LP Sells 17,087 Shares of Biogen Inc. (NASDAQ:BIIB)2 hours ago | marketbeat.comNational Bank of Canada FI Has $27.58 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)3 hours ago | marketbeat.comCharles Schwab Investment Management Inc. Buys 47,956 Shares of Biogen Inc. (NASDAQ:BIIB)3 hours ago | marketbeat.comWolfe Research Has Pessimistic Outlook of Biogen Q4 Earnings3 hours ago | americanbankingnews.comWolfe Research Issues Negative Estimate for Biogen Earnings4 hours ago | marketbeat.comBiogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of ...August 11 at 7:39 AM | gurufocus.comBiogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet SyndromeAugust 11 at 7:00 AM | globenewswire.comAigen Investment Management LP Invests $1.97 Million in Biogen Inc. (NASDAQ:BIIB)August 11 at 4:34 AM | marketbeat.comWhite Lighthouse Investment Management Inc. Takes $291,000 Position in Biogen Inc. (NASDAQ:BIIB)August 11 at 4:25 AM | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Grows Stock Holdings in Biogen Inc. (NASDAQ:BIIB)August 11 at 4:24 AM | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Holdings Decreased by Deutsche Bank AGAugust 11 at 4:23 AM | marketbeat.comKoss Olinger Consulting LLC Acquires New Shares in Biogen Inc. (NASDAQ:BIIB)August 10 at 6:49 AM | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $38.02 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)August 10 at 6:37 AM | marketbeat.comVanguard Group Inc. Buys 283,964 Shares of Biogen Inc. (NASDAQ:BIIB)August 10 at 4:37 AM | marketbeat.comGuggenheim Sticks to Their Buy Rating for Biogen (BIIB)August 9 at 6:46 PM | theglobeandmail.comBiogen (BIIB) Receives a Buy from ScotiabankAugust 9 at 6:46 PM | theglobeandmail.com10,849 Shares in Biogen Inc. (NASDAQ:BIIB) Bought by Ontario Teachers Pension Plan BoardAugust 9 at 5:53 AM | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Incyte (INCY)August 8, 2025 | theglobeandmail.comHeadlands Technologies LLC Sells 3,608 Shares of Biogen Inc. (NASDAQ:BIIB)August 8, 2025 | marketbeat.comiA Global Asset Management Inc. Acquires 2,636 Shares of Biogen Inc. (NASDAQ:BIIB)August 8, 2025 | marketbeat.comWe Think Biogen's (NASDAQ:BIIB) Profit Is Only A Baseline For What They Can AchieveAugust 7, 2025 | finance.yahoo.comPrimecap Management Co. CA Lowers Position in Biogen Inc. (NASDAQ:BIIB)August 7, 2025 | marketbeat.comBank of Nova Scotia Sells 4,241 Shares of Biogen Inc. (NASDAQ:BIIB)August 7, 2025 | marketbeat.comNatixis Advisors LLC Acquires 9,946 Shares of Biogen Inc. (NASDAQ:BIIB)August 7, 2025 | marketbeat.comUS Bancorp DE Boosts Stock Position in Biogen Inc. (NASDAQ:BIIB)August 6, 2025 | marketbeat.comBiogen (BIIB) Price Target Hiked to $130 at UBS amid Leqembi DevelopmentAugust 5, 2025 | msn.comJ. Safra Sarasin Holding AG Sells 52,864 Shares of Biogen Inc. (NASDAQ:BIIB)August 5, 2025 | marketbeat.comLSV Asset Management Grows Holdings in Biogen Inc. (NASDAQ:BIIB)August 5, 2025 | marketbeat.comArkadios Wealth Advisors Buys Shares of 3,354 Biogen Inc. (NASDAQ:BIIB)August 5, 2025 | marketbeat.comQ3 Earnings Forecast for Biogen Issued By Leerink PartnrsAugust 5, 2025 | americanbankingnews.comWedbush Has Negative Outlook for Biogen Q3 EarningsAugust 5, 2025 | americanbankingnews.comBiogen Inc. (BIIB): A Bull Case TheoryAugust 4, 2025 | insidermonkey.comBofA Lowers PT on Biogen (BIIB) to $142 From $143, Keeps a Neutral RatingAugust 4, 2025 | msn.comBiogen Inc. (BIIB): A Bull Case TheoryAugust 4, 2025 | finance.yahoo.comBanco Santander S.A. Purchases 7,182 Shares of Biogen Inc. (NASDAQ:BIIB)August 4, 2025 | marketbeat.comNicolet Advisory Services LLC Makes New Investment in Biogen Inc. (NASDAQ:BIIB)August 4, 2025 | marketbeat.comBiogen’s Strategic Pipeline Diversification and Promising Product Performance Drive Buy RatingAugust 4, 2025 | tipranks.comBiogen (NASDAQ:BIIB) Price Target Raised to $135.00August 4, 2025 | americanbankingnews.comWilliam Blair Has Negative Forecast for Biogen Q2 EarningsAugust 4, 2025 | marketbeat.comFY2025 EPS Estimates for Biogen Lifted by Cantor FitzgeraldAugust 4, 2025 | marketbeat.comLeerink Partnrs Estimates Biogen's Q3 Earnings (NASDAQ:BIIB)August 4, 2025 | marketbeat.comWedbush Forecasts Biogen's Q3 Earnings (NASDAQ:BIIB)August 4, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Releases Earnings Results, Beats Expectations By $1.54 EPSAugust 3, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Stock Holdings Boosted by R Squared LtdAugust 3, 2025 | marketbeat.comOVERSEA CHINESE BANKING Corp Ltd Increases Position in Biogen Inc. (NASDAQ:BIIB)August 3, 2025 | marketbeat.comJefferies Financial Group Inc. Has $6.84 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)August 3, 2025 | marketbeat.comMackenzie Financial Corp Acquires 12,838 Shares of Biogen Inc. (NASDAQ:BIIB)August 3, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Stock Rating Upgraded by Wall Street ZenAugust 3, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Price Target Raised to $135.00 at CitigroupAugust 2, 2025 | marketbeat.comResults: Biogen Inc. Exceeded Expectations And The Consensus Has Updated Its EstimatesAugust 2, 2025 | uk.finance.yahoo.com Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.720.47▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3624▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Today Gilead Sciences News Today Ionis Pharmaceuticals News Today Moderna News Today Prothena News Today Cassava Sciences News Today Vertex Pharmaceuticals News Today AbbVie News Today Bristol Myers Squibb News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access